IMPACT OF PRETRETMENT LEUKOCYTOSIS ON PROGNOSIS IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH CONCURRENT CHEMORADIOTHERAPY

被引：0

作者：

Topkan, Erkan ^{[1
]}

Parlak, Cem ^{[1
]}

Guler, Ozan C. ^{[1
]}

Pehlivan, Berrin ^{[2
]}

Selek, Ugur ^{[3
]}

机构：

[1] Baskent Univ, Fac Med, Dept Radiat Oncol, Ankara, Turkey

[2] Medstar Antalya Hosp, Dept Radiat Oncol, Antalya, Turkey

[3] Univ Texas MD Anderson, Radiat Oncol Ctr, Amer Hosp, Dept Radiat Oncol, Istanbul, Turkey

来源：

JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷

关键词：

locally advanced non-small cell lung cancer; Concurrent chemoradiotherapy; pretreatment white blood cell count;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MO25.08

引用

页码：S412 / S412

页数：1

共 50 条

[1] IMPACT OF PRETRETMENT LEUKOCYTOSIS ON PROGNOSIS IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH CONCURRENT CHEMORADIOTHERAPY
Topkan, Erkan
Parlak, Cem
Pehlivan, Berrin
Ozyilkan, Ozgur
Selek, Ugur
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S556 - S556
[2] The Impact of Radiation Pneumonitis on Prognosis of Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy
Akita, T.
Baba, K.
Tanaka, H.
Fujioka, I.
Suzuki, S.
Tabe, C.
Shiratori, T.
Ishioka, Y.
Itoga, M.
Taima, K.
Yokouchi, J.
Hasegawa, Y.
Takanashi, S.
Tasaka, S.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S636 - S636
[3] IMPACT OF CHANGE IN HEMOGLOBIN LEVELS DURING TREATMENT ON PROGNOSIS IN NON-ANEMIC LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH CONCURRENT CHEMORADIOTHERAPY
Topkan, Erkan
Parlak, Cem
Guler, Ozan C.
Pehlivan, Berrin
Ozyilkan, Ozgur
Selek, Ugur
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S853 - S853
[4] Concurrent Chemoradiotherapy with Biweekly Gemcitabine and Cisplatin in Patients with Locally Advanced Non-small Cell Lung Cancer
Oak, Chul Ho
Kim, Ja Kyung
La Jang, Lee
Moon, Dae Sung
Jang, Tae Won
Jung, Maan Hong
Cho, Sung Whan
Jeung, Tae Sig
RADIATION ONCOLOGY JOURNAL, 2008, 26 (03): : 160 - 165
[5] Endostar acts as a pneumonitis protectant in patients with locally advanced non-small cell lung cancer receiving concurrent chemoradiotherapy
Kuifei Chen
Shuling Li
Meng Chen
Zhicheng Jin
Xuefeng Sun
Suna Zhou
Haihua Yang
BMC Cancer, 24
[6] Endostar acts as a pneumonitis protectant in patients with locally advanced non-small cell lung cancer receiving concurrent chemoradiotherapy
Chen, Kuifei
Li, Shuling
Chen, Meng
Jin, Zhicheng
Sun, Xuefeng
Zhou, Suna
Yang, Haihua
BMC CANCER, 2024, 24 (01)
[7] Serum human epididymis protein 4 is associated with the treatment response of concurrent chemoradiotherapy and prognosis in patients with locally advanced non-small cell lung cancer
W.-G. Lan
Y.-Z. Hao
D.-H. Xu
P. Wang
Y.-L. Zhou
L.-B. Ma
Clinical and Translational Oncology, 2016, 18 : 375 - 380
[8] Serum human epididymis protein 4 is associated with the treatment response of concurrent chemoradiotherapy and prognosis in patients with locally advanced non-small cell lung cancer
Lan, W-G.
Hao, Y-Z.
Xu, D-H.
Wang, P.
Zhou, Y-L.
Ma, L-B.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (04) : 375 - 380
[9] Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
Bergamino, Milana
Rullan, Antonio J.
Saigi, Maria
Peiro, Inmaculada
Montanya, Eduard
Palmero, Ramon
Carlos Ruffinelli, Jose
Navarro, Arturo
Dolores Arnaiz, Maria
Brao, Isabel
Aso, Samantha
Padrones, Susana
Cardenal, Felipe
Nadal, Ernest
BMC CANCER, 2019, 19 (1)
[10] Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
Milana Bergamino
Antonio J. Rullan
Maria Saigí
Inmaculada Peiró
Eduard Montanya
Ramón Palmero
José Carlos Ruffinelli
Arturo Navarro
María Dolores Arnaiz
Isabel Brao
Samantha Aso
Susana Padrones
Felipe Cardenal
Ernest Nadal
BMC Cancer, 19

← 1 2 3 4 5 →